Clinical Trial Update: HR Combined With FOLFOX4 for HCC With PVTT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HR in combination with the FOLFOX4 regimen for hepatocellular carcinoma with portal vein tumor thrombus; status is not specifi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• FOLFOX4 (Folinic acid (Leucovorin), Fluorouracil (5-FU), Oxaliplatin)
• HR
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN